The other question is given Neuren’s drug was recently approved my main question is given Neuren has been granted ODD for the Rett syndrome does this give them 7 year marketing exclusivity or not? The FDA approval for Daybue didn’t mention exclusivity granted for their drug (they got paediatric rare drug PRV) so I am guessing we can also stand to get marketing approval if we fly past phase 3.
https://data-api.marketindex.com.au/api/v1/announcements/XASX:NEU:2A1436933/pdf/inline/fda-approves-daybue-the-first-treatment-for-rett-syndrome
- Forums
- ASX - By Stock
- Ann: Trading Halt
The other question is given Neuren’s drug was recently approved...
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
-0.003(4.62%) |
Mkt cap ! $63.07M |
Open | High | Low | Value | Volume |
6.3¢ | 6.7¢ | 6.2¢ | $58.27K | 911.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 248852 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.3¢ | 75967 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 264982 | 0.062 |
1 | 49195 | 0.061 |
2 | 176666 | 0.060 |
2 | 66955 | 0.059 |
1 | 10000 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 78819 | 1 |
0.066 | 257847 | 1 |
0.070 | 63738 | 2 |
0.074 | 123500 | 2 |
0.075 | 27637 | 1 |
Last trade - 15.50pm 04/06/2024 (20 minute delay) ? |
|
|||||
Last
6.4¢ |
  |
Change
-0.003 ( 3.03 %) |
|||
Open | High | Low | Volume | ||
6.5¢ | 6.8¢ | 6.3¢ | 337484 | ||
Last updated 15.27pm 04/06/2024 ? |
Featured News
NTI (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online